News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
281,793 Results
Type
Article (9149)
Company Profile (20)
Press Release (272624)
Multimedia
Podcasts (21)
Webinars (4)
Section
Business (96427)
Career Advice (1064)
Deals (17420)
Drug Delivery (28)
Drug Development (32689)
Employer Resources (41)
FDA (5681)
Job Trends (5511)
News (151230)
Policy (10195)
Tag
Academia (568)
Accelerated approval (2)
Adcomms (9)
Allergies (32)
Alliances (17459)
ALS (36)
Alzheimer's disease (442)
Antibody-drug conjugate (ADC) (75)
Approvals (5705)
Artificial intelligence (89)
Autoimmune disease (11)
Automation (3)
Bankruptcy (122)
Best Places to Work (4357)
BIOSECURE Act (2)
Biosimilars (31)
Biotechnology (24)
Bladder cancer (39)
Brain cancer (16)
Breast cancer (148)
Cancer (1038)
Cardiovascular disease (71)
Career advice (847)
Career pathing (11)
CAR-T (69)
Cell therapy (201)
Cervical cancer (8)
Clinical research (27641)
Collaboration (305)
Compensation (203)
Complete response letters (9)
COVID-19 (760)
CRISPR (16)
C-suite (175)
Cystic fibrosis (28)
Data (1054)
Denatured (1)
Depression (20)
Diabetes (95)
Diagnostics (2609)
Digital health (4)
Diversity, equity & inclusion (14)
Drug discovery (34)
Drug pricing (19)
Drug shortages (6)
Duchenne muscular dystrophy (37)
Earnings (47389)
Editorial (12)
Employer branding (7)
Employer resources (42)
Events (45347)
Executive appointments (539)
FDA (6271)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (3)
Frontotemporal dementia (6)
Funding (308)
Gene editing (41)
Generative AI (5)
Gene therapy (133)
GLP-1 (283)
Government (909)
Grass and pollen (1)
Guidances (104)
Healthcare (6809)
Huntington's disease (10)
IgA nephropathy (9)
Immunology and inflammation (52)
Indications (13)
Infectious disease (805)
Inflammatory bowel disease (50)
Inflation Reduction Act (5)
Influenza (17)
Intellectual property (28)
Interviews (182)
IPO (9067)
IRA (8)
Job creations (1315)
Job search strategy (749)
Kidney cancer (7)
Labor market (16)
Layoffs (174)
Leadership (13)
Legal (2587)
Liver cancer (35)
Lung cancer (153)
Lymphoma (86)
Machine learning (4)
Management (14)
Manufacturing (95)
MASH (46)
Medical device (5292)
Medtech (5293)
Mergers & acquisitions (8673)
Metabolic disorders (283)
Multiple sclerosis (31)
NASH (16)
Neurodegenerative disease (32)
Neuropsychiatric disorders (6)
Neuroscience (655)
NextGen: Class of 2025 (2253)
Non-profit (1251)
Now hiring (5)
Obesity (141)
Opinion (92)
Ovarian cancer (38)
Pain (30)
Pancreatic cancer (39)
Parkinson's disease (53)
Partnered (6)
Patents (43)
Patient recruitment (57)
Peanut (16)
People (29621)
Pharmaceutical (9)
Pharmacy benefit managers (2)
Phase I (8861)
Phase II (11878)
Phase III (9732)
Pipeline (887)
Policy (31)
Postmarket research (906)
Preclinical (2768)
Press Release (67)
Prostate cancer (59)
Psychedelics (10)
Radiopharmaceuticals (138)
Rare diseases (155)
Real estate (2142)
Recruiting (13)
Regulatory (7410)
Reports (17)
Research institute (580)
Resumes & cover letters (191)
Rett syndrome (5)
RNA editing (1)
RSV (12)
Schizophrenia (39)
Series A (53)
Series B (41)
Sickle cell disease (24)
Special edition (7)
Spinal muscular atrophy (50)
Sponsored (7)
Startups (1267)
Stomach cancer (5)
Supply chain (23)
Tariffs (10)
The Weekly (20)
Vaccines (182)
Venture capitalists (15)
Weight loss (91)
Women's health (6)
Worklife (8)
Date
Today (17)
Last 7 days (500)
Last 30 days (1375)
Last 365 days (14551)
2025 (5398)
2024 (15838)
2023 (17963)
2022 (23768)
2021 (25174)
2020 (23122)
2019 (17623)
2018 (13320)
2017 (13293)
2016 (11875)
2015 (15115)
2014 (11625)
2013 (9200)
2012 (9875)
2011 (10412)
2010 (9864)
Location
Africa (287)
Alabama (17)
Alaska (5)
Arizona (65)
Arkansas (5)
Asia (16404)
Australia (2675)
California (3060)
Canada (944)
China (200)
Colorado (122)
Connecticut (144)
Delaware (68)
Europe (35054)
Florida (397)
Georgia (68)
Idaho (28)
Illinois (199)
India (12)
Indiana (113)
Iowa (3)
Japan (122)
Kansas (35)
Kentucky (11)
Louisiana (6)
Maine (47)
Maryland (311)
Massachusetts (2228)
Michigan (97)
Minnesota (195)
Mississippi (1)
Missouri (40)
Montana (16)
Nebraska (15)
Nevada (31)
New Hampshire (31)
New Jersey (854)
New Mexico (8)
New York (725)
North Carolina (439)
North Dakota (3)
Northern California (1423)
Ohio (97)
Oklahoma (5)
Oregon (6)
Pennsylvania (584)
Puerto Rico (1)
Rhode Island (21)
South America (426)
South Carolina (9)
Southern California (1126)
Tennessee (53)
Texas (369)
United States (10648)
Utah (94)
Virginia (63)
Washington D.C. (19)
Washington State (246)
West Virginia (2)
Wisconsin (35)
281,793 Results for "i3 corporation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Bayer Initiates Phase I Study Targeting GPC3 With Actinium-225 Radiopharmaceutical in Patients With Advanced Hepatocellular Carcinoma
April 29, 2025
·
6 min read
Press Releases
Vividion Therapeutics Doses First Patient in Phase I Study of RAS-PI3Kα Inhibitor for Treatment of Advanced Solid Tumors
April 3, 2025
·
5 min read
Policy
C3i Center Inc is First CDMO in Canada to Receive Approval for a Drug Establishment License to Commercially Produce Cell Therapy Drug Products
C3i Center Inc (C3i) announced it has received regulatory approval, in the form of a Drug Establishment License (DEL), to commercially produce cell therapies, making C3i the first CDMO in Canada to achieve this milestone.
June 20, 2024
·
2 min read
Press Releases
C3i Center, a Canadian company, receives approval from the EMA to manufacture cell therapy products for the European market
February 19, 2025
·
2 min read
Press Releases
I-Mab to Release Q3 2024 Financial Results on November 14, 2024
November 1, 2024
·
1 min read
Press Releases
Attralus Announces Enrollment of First Patient in Phase 3 Trial for the Pan-Amyloid Diagnostic 124I-evuzamitide (AT-01) for Cardiac Amyloidosis
January 15, 2025
·
6 min read
Press Releases
Corporate Update: Psyence Biomedical Ltd Redefines Psychedelic Medicine with a Multi-Asset Strategy, Advancing Clinical Trials and Scalable Manufacturing
Company executives will host a corporate webinar for investors and stakeholders on Thursday, April 10, 2025
March 31, 2025
·
12 min read
Press Releases
Hemogenyx Pharmaceuticals PLC - FLT3 Assay Ready for Phase I Trials at MD Anderson
September 9, 2024
·
4 min read
BoomRay’s Radioactive Diagnostic New Drug [18F]BF3-BPA Injection Completes First Subject Enrollment in Phase I Clinical Trial
BoomRay Pharmaceutical Co., Ltd. (“BoomRay”) announced that the phase I clinical trial of its positron emission tomography (PET) tracer [18F]BF3-BPA injection for the diagnosis of primary and metastatic brain tumors has completed the enrollment of the first subject.
April 22, 2024
·
2 min read
Press Releases
ABIONYX Pharma, winner of the France 2030 Plan’s “i-Démo” call for projects, awarded €8.7 million from the French government to fight against Sepsis, the 3rd leading cause of death worldwide
February 20, 2025
·
1 min read
1 of 28,180
Next
